Epoetin alpha and high-dose chemotherapy;Impiego di eritropoietina alfa nei programmi di chemioterapia ad alte dosi

Recenti Progressi in Medicina

Volumn 91, Issue 12, 2000, Pages 681-689

  Danova, Marco ^a   Aglietta, Massimo ^b   Pierelli, Luca ^c   Ferrari, Silvia ^a   Perillo, Alessandro ^c   Scambia, Giovanni ^c   Henry, David ^d  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d PENNSYLVANIA HOSPITAL   (United States)

Author keywords

Autologous and allogeneic bone arrow transplantation; Circulating progenitor cell mobilization; Erythropoietin; High dose chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; RECOMBINANT ERYTHROPOIETIN;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANEMIA; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLOOD TRANSFUSION; BONE MARROW SUPPRESSION; CANCER; CANCER CHEMOTHERAPY; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; REVIEW; STEM CELL; TREATMENT FAILURE; TREATMENT OUTCOME;

ANEMIA; ANTINEOPLASTIC AGENTS; BLOOD TRANSFUSION; BONE MARROW; DRUG ADMINISTRATION SCHEDULE; EPOETIN ALFA; ERYTHROPOIETIN; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HEMOGLOBIN A; HUMANS;

EID: 0034533847     PISSN: 00341193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Erslev AJ. Erythropoietin therapy. New Engl J Med 1991; 324: 1339-44.
2. Tilbrook PA, Klinken PS. Erythropoietin and erythropoietin receptor. Growth Factors 1999; 17: 25-35.
3. Ebert BL, Bunn F. Regulation of the erythropoietin gene. Blood 1999; 94: 1864-77.
4. Goodnough LT, Skikne B, Brugnara C. Erythropoietin, iron and erythropoiesis. Blood 2000; 96: 823-33.
5. Miller CB, Jones RE, Mariana LZ, et al. Impaired erythropoietin response to anemia after bone marrow transplantation. Blood 1992; 10: 2677-82.
6. Beguin Y, Clemons GK, Oris R, et al. Circulating erythropoietin levels after bone marrow transplantation: inappropriate response to anemia in allogeneic transplants. Blood 1991; 77: 868-73.
7. Schapira L, Anton JH, Ransil B, et al.: Serum erythropoietin levels in patients receiving intensive chemotherapy and radiotherapy. Blood 1990; 76: 2355-59.
8. Ireland RM, Atkinson K, Concannon A, et al. Serum erythropoietin changes in autologous and allogeneic bone marrow transplant patients. Br J Hematol 1990; 76: 128-34.
9. Steegman J, Lopez J, Otero M, et al. Erythropoietin treatment in allogeneic bone marrow transplantation accelerates erythroid reconstitution. Results of a prospective, controlled, randomized trial. Bone Marrow Transplant 1991, 10: 541-6.
10. Klaesson S, Ringden O, Ljungman P, et al. Reduced blood transfusion requirements after allogeneic bone marrow transplantation. Results of a randomized, double-blind study with high dose erythropoietin. Bone Marrow Transplant 1994; 13: 397-402.
11. Locatelli F, Zecca M, Pedrazzoli P, et al. Use of recombinant human erythropoietin after bone marrow transplantation in pediatric patients with acute leukemia: effect on erythroid repopulation in autologous versus allogeneic transplants. Bone Marrow Transplant 1994; 13: 403-10.
12. Vannuchi A.M., Bosi A., Ieri A., et al. Combination therapy with G-CSF and erythropoietin after autologous bone marrow transplantation for lymphoid malignancies: a randomized trial. Bone Marrow Transplant 1996; 17: 527-531.
13. Klaesson S. Clinical use of rHuEpo in bone marrow transplantation Med Oncol 1999; 16(1): 2-7.
14. Peliska J, Miller C, Bishop M, et al. Recombinant human etythropoietin therapy for patients with delayed anemia after bone marrow transplantation. Blood 1993; 89: 639 (abs).
15. Estrin JT, Ford PA, Henry DH, et al. Erythropietin permits high-dose chemotherapy with peripheral blood stem-cell transplantation for a jehovais witness. Am J Hematol, 1997; 55(1): 51-2.
16. Henry DH, Mason BA, Staddon AP, Ford PA, Matthews B. Epoetin alpha prior to high-dose chemotherapy (HDCT) and autologous stem cell rescue. Eur J Cancer 1999; 35 (S4): 1190 (abs).
17. Ponchio L, Zambelli A, De Stefano A, et al. Transfusion requirement can be abolished by epoietin-a and autologous platelet predeposit in patients receiving high dose chemotherapy with stem cell support. Haematologica 2000; 85: 219-20.
18. Danova M, Airoldi M, Brugnatelli S, et al. Erythropoietin administration before high-dose chemotherapy in breast cancer: a strategy to decrease the anemia in this setting. Bone Marrow Transplant 2000; 26(1): 31(abs).
19. Morstyn G, Souza LM, Keech J, et al. Effect of granulocyte colony-stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1998; 1: 667-72.
20. Sheridan WP, Begley CG, Juttner CA, et al. Effect of peripheral blood progenitor cell mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1992; 339: 640-44.
21. Pierelli L, Men chella G, Scambia G, et al. In vitro and in vivo effects of recombinant human erythropoietin plus recombinant G-CSF on human haematopoietic progenitor cells. Bone Marrow Transplant 1994; 14: 23-30.
22. Olivieri A, Offidani M, Cantori I, et al. Addition of erythropoietin to granulocyte colony-stimulating factor after priming chemotherapy enhances hemopoietic progenitor mobilization. Bone Marrow Transplant 1995; 16: 765-770.
23. Pene R, Appelbaum FR, Fisher K, et al. Use of granulocyte-macrophage colony-stimulating factor and erythropoietin in combination after autologous marrow transplantation. Bone Marrow Transplant 1993; 11: 219-22.
24. Pierelli L, Perillo A, Greggi S, et al. Erythropoietin addition to granulocyte colony-stimulating factor abrogates life-threatening neutropenia and increases peripheral-blood progenitor-cell mobilization after epirubicin, paclitaxel and cisplatin combination chemotherapy: results of a randomized comparison. J Clin Oncol 1999; 17: 1288-95.
25. Ferrari S, Danova M, Porta C, et al. Circulating progenitor cell release and functional characterization after topotecan plus G-CSF and erythropoietin in small cell lung cancer patients. Int J Oncol 1999; 15: 811-15.